Vascular Stents Market size Scope and Opportunities Analysis to size 2025Posted by ved123 on December 26th, 2019 Vascular Stents Market: Overview Vascular stents are thin, tiny mesh like tubes placed into blood vessels and other hollow structures to open blockage of vessels through the procedure of vascular stenting. These stents open narrowed vessels, reduce vessel blockage and maintain continuous flow of dissolved nutrients through circulatory system. Stent tubes are made up of plastic or metal mesh like materials. Two common types of stents in the global vascular stent market include bare metal stents and covered stents, also known as stent grafts. The vascular stents market is forecasted to reach US$ xx Billion by 2022 from xx Billion in 2018, at a CAGR of xx % from 2018 to 2025. The growth in the global vascular stents market is due to rising geriatric population, increasing angioplasty procedures and increasing demand for the minimally invasive procedures. The expansion in the emerging markets and the development of bio-resorbable vascular scaffolds are expected to offer potential growth opportunities to the key players in the coming forecast period.However, the global vascular stents market is restrained by stringent regulations, alternative treatment methods and products failures and recalls. Get Enquiry More About This Report: https://www.trendsmarketresearch.com/report/sample/3640 Vascular Stents Market: Segmentation The global vascular stents market is segmented on basis of type, mode of delivery, product, material, end user, and region. Based on product the market is segregated into peripheral stents, coronary stents and EVAR stents. The coronary stent segment dominated the market in 2018, due to increasing incidences of coronary artery disease and the technological advancements. Vascular Stent Market, by Type Coronary Stents Bare-metal Stents Balloon-expandable Stents Metallic Stents Vascular Stent Market, by End User Hospitals & Cardiac Centers The major players operating in the global vascular stents market include Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), B. Braun Melsungen AG (Germany), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), W. L. Gore and Associates (U.S.), C. R. Bard (U.S.), Medtronic, plc (Ireland), BIOTRONIK SE & Co. KG (Germany), Medtronic, plc (Ireland), Translumina GmbH (Germany), and JOTEC GmbH (Germany). Endologix, Inc. (U.S.), and Lombard Medical Technologies (U.K.). Like it? Share it!More by this author |